Ladenburg Thalmann Starts Nektar Therapeutics (NKTR) at Buy
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $72.74 --0%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 21
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 12 | New: 21
Join SI Premium – FREE
Ladenburg Thalmann initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $12.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Starts Vishay Intertechnology (VSH) at Buy
- Morgan Stanley Resumes Partners Group Holding AG (PGHN:SW) (PGPHF) at Equalweight
- H.C. Wainwright Starts NeuroSense Therapeutics Ltd. (NRSN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
